Journal articles
- Research
- Our research
- Research news
- Journal articles
- Research Summit
- Research Excellence Awards
- Research Excellence Awards 2026
- Research Excellence Awards 2025
- Research Excellence Awards 2024
- Research Excellence Awards 2023
- Research Excellence Awards 2022
- Research Excellence Awards 2021
- Research Excellence Awards 2020
- Research Excellence Awards 2019
- Research Excellence Awards 2018
- Research Excellence Awards 2017
- Reporting
- For patients and consumers
- Clinical trials
- Pre-approval planning
- Ethics approval
- Research governance
- Post-approval submissions
- Supporting research
- Contact us
- Our research
Metro North is committed to providing a platform to acknowledge and promote research excellence within our health service. Below is a list of research publications from across our hospitals and services.
- Management of acute hyperkalaemia: evidence, practice and pitfalls 27 October 2026Acute hyperkalaemia is a medical emergency requiring rapid clinical evaluation. Point-of-care blood gas analysis may overestimate serum potassium concentration and should be confirmed with a laboratory sample unless urgent treatment is required. When ECG (electrocardiogram) changes are present, immediate cardiac protection is a priority. Current guidelines recommend administering intravenous 10% calcium gluconate to restore cardiac […]Samuel Ford
- Cardiac amyloidosis: recognition, diagnosis and management 27 October 2026Cardiac amyloidosis is an under-recognised but treatable condition characterised by insoluble protein deposition in the heart and is associated with high morbidity and mortality. It is most commonly caused by transthyretin (known as transthyretin [ATTR] amyloidosis) but may also be caused by a plasma cell dyscrasia (known as light chain [AL] amyloidosis). Cardiac amyloidosis should […]Natasha Gorrie
- Improving Acute Resuscitation Plan Completion Rates Using Visual Aids in an Inpatient Setting: A Quality Improvement Study 27 October 2026Background An Acute Resuscitation Plan (ARP) is a document that helps medical professionals incorporate the wishes of patients and their families, as well as the opinions of the treating team, when making decisions about treatment escalation and whether resuscitation is appropriate should a patient clinically deteriorate. This project aimed to assess if the use of […]Michael T Byrne
- Non-Invasive Distal Airway Proteomics by Particles in Exhaled Air (PExA) Sampling Demonstrates Shared Proteomic Features with Matched Bronchoalveolar Lavage 27 October 2026Repeated molecular sampling of the distal airways is constrained by the invasive nature of bronchoalveolar lavage (BAL), limiting its use in healthy control populations, longitudinal studies, clinical trials and occupational screening. Particles in exhaled air (PExA) sampling offers a non-invasive approach to distal-airway sampling, although whether it captures the same proteins and relative protein abundance […]Kiara M Knuckey
- Workplace and personal predictors of well-being in the broader maternity and neonatal workforce during COVID-19: evidence from a multicentre survey 26 October 2026CONCLUSION: Workplace-related and personal factors significantly influenced maternity and neonatal staff well-being during the pandemic. Addressing workplace stress, promoting sleep, supporting healthy coping mechanisms, and encouraging restorative activities may improve staff well-being. These findings can inform the design of targeted workforce support programs and guide service planning strategies to strengthen resilience during future system shocks.Alexander J Lindgren
- Medical emergency response related to MedicAtion InciDents (MERRMAID): a case series and lessons to improve medication safety 26 October 2026CONCLUSIONS: Medication adverse events due to potentially error-prone steps in medication management processes are a common cause of inpatient MERT activations, presenting a considerable preventable burden to patients and healthcare resources.Ian Coombes
- Weight Stigma in Pregnancy: A Narrative Review of Consequences, Drivers, and Potential Solutions 26 October 2026PURPOSE OF REVIEW: This narrative review summarises current knowledge of weight stigma in pregnancy including consequences, drivers, and potential solutions.Briony Hill
- Laplace-based cortical thickness without volumetric discretisation 26 October 2026Laplace-based methods define cortical thickness as the length of a streamline connecting the pial and white surfaces, but existing implementations discretize the volume and lose accuracy in tight folds. Surface-based methods use Euclidean inter-surface distances that cannot enforce orthogonal, non-crossing correspondences. We solve Laplace's equation on the cortical surface itself using a boundary element method, […]Alastair Snell
- The secret life of dialysis catheters: A qualitative study of intensive care nurses' experiences of managing dialysis catheters 26 October 2026CONCLUSION: The absence of evidence-based guidance to manage troubleshooting and catheter dysfunction places substantial burden on ICU nurses. Evidence-based troubleshooting decision tools may have the potential to improve dialysis efficiency, reduce healthcare-associated risks and workforce stress.Amanda Corley
- Moving towards evidence-based screening and investigations in first episode psychosis: A commentary on the ANZJP GRADE Schizophrenia Guidelines 25 October 2026Physical health assessment and investigations are important considerations during the first episode of psychosis. These activities support diagnostic clarification, monitoring for iatrogenic harms and opportunistic screening to limit the multimorbidity that is often associated with psychotic disorders in the longer term. The recent 'Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development […]Kirk Chalmers
- Phase II Study of Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous Cell Carcinoma: Final Analysis 24 October 2026We previously reported the results of a multicenter phase II trial (ClinicalTrials.gov identifier: NCT04154943) of neoadjuvant cemiplimab in resectable stage II to IV cutaneous squamous cell carcinoma (CSCC), in which the pathologic complete response (pCR) rate was 51%. At the 19-month follow-up, estimated 12-month event-free survival (EFS) was 89%, with 11 EFS events. In this […]Neil D Gross
- Qualitative analysis of staff views on caring for inpatients with delirium and Parkinson's disease: Challenges, tensions and team working 24 October 2026ObjectivesPeople with Parkinson's disease (PD) are at increased risk of delirium. Documentation of delirium is poor, with challenges in making a diagnosis due to overlapping symptoms. This study interviewed healthcare workers about their experiences of caring for inpatients with PD and delirium to explore their perspectives.DesignA qualitative study with semi-structured interviews and thematic analysis.ParticipantsTwelve healthcare […]Rachel Cullinan
- A prospective controlled study assessing postpartum breastfeeding in women with type 2 diabetes: lower rates associated with elevated BMI rather than diabetes 23 October 2026CONCLUSIONS/INTERPRETATION: Maternal obesity, rather than type 2 diabetes, may be the major determinant of reduced breastfeeding rates 4 months postpartum.Fiona L Britten
- An Exploratory Longitudinal Analysis of Salivary Host, Bacterial and Fungal Extracellular Vesicles Following 6-Month Non-Surgical Periodontal Therapy in Periodontitis 23 October 2026CONCLUSIONS: NSPT led to changes in salivary host and non-host EV cargoes, suggesting that they may serve as a non-invasive tool for disease treatment monitoring in periodontitis.Chun Liu
- TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of <sup>212</sup>Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer 23 October 2026[^(212)Pb]Pb-ADVC001 (^(212)Pb-ADVC001) is a prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy with high linear energy transfer derived predominantly from the alpha-emission of its ^(212)Pb payload which, upon decay, delivers potent ionizing radiation directly to the tumor. TheraPb (NCT05720130) is a first-in-human dose-escalation and optimization study evaluating ^(212)Pb-ADVC001 in metastatic androgen pathway modulation-resistant prostate cancer (mAPM-R, formerly...Aaron R Hansen
